From rats to man: A perspective an dietary L-arginine supplementation in human renal disease

Nephrology Dialysis Transplantation

Volumn 14, Issue 7, 1999, Pages 1640-1650

  Peters, Harm ^a,c   Border, Wayne A ^b   Noble, Nancy A ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Fibrosis; Injury; L arginine; Repair; TGF

Indexed keywords

ARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; DIETARY INTAKE; IMMUNOMODULATION; KIDNEY DISEASE; KIDNEY FIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN RESTRICTION; RAT; REVIEW;

ANIMALS; ARGININE; DIET; DIETARY SUPPLEMENTS; HUMANS; KIDNEY DISEASES; MODELS, BIOLOGICAL; NITRIC OXIDE; ORNITHINE; RATS;

EID: 0033000266     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.7.1640     Document Type: Review

References (99)

1. Reyes AA, Karl IE, Klahr S. Role of arginine in health and in renal disease. Am J Physiol 1994; 267: F331-F346
2. Peters H, Noble NA. Dietary L-arginine in renal disease. Semin Nephrol 1996; 16: 567-575
3. Cianciaruso B, Bellizzi V, Minutolo R et al. Chronic supplementation of L-arginine (ARG) in patients with moderate renal failure (CRF) secondary to chronic glomerulonephritis (GN). J Am Soc Nephrol 1996; 7: 1316-1310 [Abstract]
4. Wolf SC, Erley CM, Kenner S, Berger ED, Risler T. Does L-arginine alter proteinuria and renal hemodynamics in patients with chronic glomerulonephritis and hypertension? Clin Nephrol 1995; 43: S42-S46
5. Reyes AA, Purkerson ML, Karl I, Klahr S. Dietary supplementation with L-arginine ameliorates the progression of renal disease in rats with subtotal nephrectomy. Am J Kidney Dis 1992; 20: 168-176
6. Katoh T, Takahashi K, Klahr S, Reyes AA, Badr KF. Dietary supplementation with L-arginine ameliorates glomerular hypertension in rats with subtotal nephrectomy. J Am Soc Nephrol 1994; 4: 1690-1694
7. Reyes AA, Porras BH, Chasalow FI, Klahr S. L-Arginine decreases the infiltration of the kidney by macrophages in obstructive nephropathy and puromycin-induced nephrosis. Kidney Int 1994; 45: 1346-1354
8. Reyes AA, Karl IE, Yates J, Klahr S. Low plasma and renal tissue levels of L-arginine in rats with obstructive nephropathy. Kidney Int 1994; 45: 782-787
9. Morrissey JJ, Ishidoya S, McCracken R, Klahr S. Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. J Am Soc Nephrol 1996; 7: 2202-2212
10. Reyes AA, Karl IE, Kissane J, Klahr S. L-Arginine administration prevents glomerular hyperfiltration and decreases proteinuria in diabetic rats. J Am Soc Nephrol 1993; 4: 1039-1045
11. Chen PY, St John PL, Kirk KA, Abrahamson DR, Sanders PW. Hypertensive nephrosclerosis in the Dahl/Rapp rat. Initial sites of injury and effect of dietary L-arginine supplementation. Lab Invest 1993; 68: 174-184
12. De Nicola L, Thomson SC, Wead LM, Brown MR, Gabbai FB. Arginine feeding modifies cyclosporine nephrotoxicity in rats. J Clin Invest 1993; 92: 1859-1865
13. Ashab I, Peer G, Blum M et al. Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production. Kidney Int 1995; 47: 1515-1521
14. Amore A, Gianoglio B, Ghigo D et al. A possible role for nitric oxide in modulating the functional cyclosporine toxicity by arginine. Kidney Int 1995; 47: 1507-1514
15. Yang CW, Kim YS, Kim J et al. Oral supplemental of L-arginine prevents chronic cyclosporine nephrotoxicity in rats. J Am Soc Nephrol 1997; 8: A2842 [Abstract]
16. Reckelhoff JF, Kellum JA, Jr, Racusen LC, Hildebrandt DA. Long-term dietary supplementation with L-arginine prevents age-related reduction in renal function. Am J Physiol 1997; 272: R1768-774
17. Andrade L, Campos SB, Seguro AC. Hypercholesterolemia aggravates radiocontrast nephrotoxicity: protective role of L-arginine. Kidney Int 1998; 53: 1736-1742
18. Narita I, Border WA, Ketteler M, Noble NA. Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis. Lab Invest 1995; 72: 17-24
19. Narita I, Border WA, Ketteler M, Ruoslahti E, Noble NA. L-Arginine may mediate the therapeutic effects of low protein diets. Proc Natl Acad Sci USA 1995; 92: 4552-4556
20. Moncada S. Nitric oxide in the vasculature: physiology and pathophysiology. Ann NY Acad Sci 1997; 811: 60-67
21. Kone BC. Nitric oxide in renal health and disease. Am J Kidney Dis 1997; 30: 311-333
22. Peters H, Border WA, Noble NA. Low protein diet and L-arginine supplementation produce additive therapeutic effects on mesangiproliferative glomerunephrtitis in the rat. J Invest Med 1997; 45: A277 [Abstract]
23. Peters H, Border WA, Noble NA. L-Arginine supplementaion increases mesangial cell injury and subsequent tissue fibrosis in experimental glomerulonephritis: Kidney Int 1999; (in press):
24. Hedin SG. Eine Methode das Lysin zu isolieren, nebst einigen Bermerkungen ueber das Lysatinin. Z Physiol Chem 1895; 21: 297-305
25. Krebs HA, Henseleit H. Untersuchungen ueber die Harstoffbildung im Tierkoerper. Z Physiol Chem 1932; 210: 33-66
26. Foster GL, Schoenheimer R, Rittenberg D. Studies in protein metabolism. V. The utilization of ammonia for amino acid and creatinine formation in animals. J Biol Chem 1939; 127: 319-327
27. Li G, Regunathan S, Barrow CJ, Eshraghi J, Copper R, Reis DJ. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 1994; 263: 966-969
28. Barbul A. Arginine: biochemistry, physiology, and therapeutic implications. J Parenter Enteral Nutr 1986; 10: 227-238
29. Forstermann U, Closs EI, Pollock JS et al. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension 1994; 23: 1121-1131
30. Castillo L, Sanchez M, Vogt J et al. Plasma arginine, citrulline, and ornithine kinetics in adults, with observations on nitric oxide synthesis. Am J Physiol 1995; 268: E360-E367
31. Castillo L, Chapman TE, Sanchez M et al. Plasma arginine and citrulline kinetics in adults given adequate and arginine-free diets. Proc Natl Acad Sci USA 1993; 90: 7749-7753
32. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996; 271: C1424-C1437
33. Peters H, Border WA, Noble NA. Angiotensin II and L-arginine in tissue fibrosis: more than blood pressure. Kidney Int 1997; 51: 1481-1486
34. Moncada S, Higgs A, Furchgott R. International Union of Pharmacology Nomenclature in Nitric Oxide Research. Pharmacol Rev 1997; 49: 137-142
35. Huang PL, Fishman MC. Genetic analysis of nitric oxide synthase isoforms: targeted mutation in mice. J Mol Med 1996; 74: 415-421
36. Trachtman H, Futterweit S, Singhal P. Nitric oxide modulates the synthesis of extracellular matrix proteins in cultured rat mesangial cells. Biochem Biophys Res Commun 1995; 207: 120-125
37. Trachtman H, Futterweit S, Garg P, Reddy K, Singhal PC. Nitric oxide stimulates the activity of a 72-kDa neutral matrix metalloproteinase in cultured rat mesangial cells. Biochem Biophys Res Commun 1996; 218: 704-708
38. Craven PA, Studer RK, Felder J, Phillips S, DeRubertis FR. Nitric oxide inhibition of transforming growth factor-beta and collagen synthesis in mesangial cells. Diabetes 1997; 46: 671-681
39. Bachmann S, Mundel P. Nitric oxide in the kidney: synthesis, localization, and function. Am J Kidney Dis 1994; 24: 112-129
40. Jenkinson CP, Grody WW, Cederbaum SD. Comparative properties of arginases. Comp Biochem Physiol B Biochem Mol Biol 1996; 114: 107-132
41. Shih VE. Regulation of ornithine metabolism. Enzyme 1981; 26: 254-258
42. Yeatman TJ, Risley GL, Brunson ME. Depletion of dietary arginine inhibits growth of metastatic tumor. Arch Surg 1991; 126: 1376-1381
43. Sanada Y, Suemori I, Katunuma N. Properties of ornithine aminotransferase from rat liver, kidney and small intestine. Biochim Biophys Acta 1970; 220: 780-792
44. Smith RJ, Phang M. Proline metabolism in cartilage: the importance of proline biosynthesis. Metabolism 1978; 27: 685-694
45. Mezl AV, Knox WE. Metabolism of arginine in lactating rat mammary gland. Biochem J 1977; 164: 105-113
46. Cook HT, Jansen A, Lewis S et al. Arginine metabolism in experimental glomerulonephritis: interaction between nitric oxide synthase and arginase. Am J Physiol 1994; 267: F646-F653
47. Jansen A, Lewis S, Cattell V, Cook HT. Arginase is a major pathway of L-arginine metabolism in nephritic glomeruli. Kidney Int 1992; 42: 1107-1112
48. Albina JE, Mills CD, Barbul A et al. Arginine metabolism in wounds. Am J Physiol 1988; 254: E459-E467
49. Albina JE, Mills CD, Henry WL, Jr., Caldwell MD. Temporal expression of different pathways of L-arginine metabolism in healing wounds. J Immunol 1990; 144: 3877-3880
50. Ketteler M, Ikegaya N, Brees DK, Border WA, Noble NA. L-Arginine metabolism in immune-mediated glomerulonephritis in the rat. Am J Kidney Dis 1996; 28: 878-887
51. Morrissey J, McCracken R, Ishidoya S, Klahr S. Partial cloning and characterization of an arginine decarboxylase in the kidney. Kidney Int 1995; 47: 1458-1461
52. Lortie MJ, Novotny WF, Peterson OW et al. Agmatine, a bioactive metabolite of arginine. Production, degradation, and functional effects in the kidney of the rat. J Clin Invest 1996; 97: 413-420
53. Schwartz D, Peterson OW, Mendonca M, Satriano J, Lortie M, Blantz RC. Agmatine affects glomerular filtration via a nitric oxide synthase-dependent mechanism. Am J Physiol 1997; 272: F597-601
54. Morrissey JJ, Klahr S. Agmatine activation of nitric oxide synthase in endothelial cells. Proc Assoc Am Physicians 1997; 109: 51-57
55. Galea E, Regunathan S, Eliopoulos V, Feinstein DL, Reis DJ. Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem J 1996; 316: 247-249
56. Satriano J, Matsufuji S, Murakami Y et al. Agmatine suppresses proliferation by frameshift induction of antizyme and attenuation of cellular polyamine levels. J Biol Chem 1998; 273: 15313-15316
57. Guigliano D, Marfella R, Verrazo G, Acampora R, Coppola L, Cozzolino D. The vascular effects of L-arginine in humans. J Clin Invest 1997; 99: 433-438
58. Castillo L, Ajami A, Branch S et al. Plasma arginine kinetics in adult man: response to an arginine-free diet. Metabolism 1994; 43: 114-122
59. Seifter E, Rettura G, Barbul A, Levenson SM. Arginine: an essential amino acid for injured rats. Surgery 1978; 84: 224-230
60. Levillain O, Hus Citharel A, Morel F, Bankir L. Localization of arginine synthesis along rat nephron. Am J Physiol 1990; 259: F916-F923
61. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994; 331: 1286-1292
62. Noble NA, Border WA. Angiotensin II in renal fibrosis: Should TGF-beta rather than blood pressure be the therapeutic target? Semin Nephrol 1997; 17: 455-466
63. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature 1990; 346: 371-374
64. Yamamoto T, Noble NA, Miller DE et al. Increased levels of TGF-beta in HIV-Associated Nephropathy. Kidney Int 1999; 55: 579-594
65. Border WA, Noble NA. Interactions of TGF-beta and Angiotensin II in renal fibrosis. Hypertension 1998; 31 [Suppl]: 181-188
66. Kagami S, Border WA, Miller DE, Noble NA. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 1994; 93: 2431-2437
67. Kagami S, Kuhura T, Okuda K, Border WA, Noble NA. Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells. Kidney Int 1997; 51: 664-671
68. Kanai H, Centrella M, Noble NA, Border WA. Angiotensin II upregulates the expression of TGF-beta type I and type II receptors. J Am Soc Nephrol 1997; 8: 518 [Abstract]
69. de Heer E, Brees DK, Bergijk EC et al. Inherited transient deficiency during mesangial immune injury is associated with persistent mesangial sclerosis. J Am Soc Nephrol 1997; 8: 513 [Abstract]
70. Border WA, Noble NA, Yamamoto T et al. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 1992; 360: 361-364
71. Isaka Y, Brees DK, Ikegaya K et al. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 1996; 2: 418-423
72. Peters H, Noble NA, Border WA. Targeting TGF-beta overexpression in renal disease: Maximizing the antifibrotic action of angiotensin II blockade. Kidney Int 1998; 54: 1575-1583
73. Cattell V, Smith J, Jansen A, Riveros Moreno V, Moncada S. Localization of inducible nitric oxide synthase in acute renal allograft rejection in the rat. Transplantation 1994; 58: 1399-1402
74. Weinberg JB, Granger DL, Pisetsky DS et al. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. J Exp Med 1994; 179: 651-660
75. Cook HT, Ebrahim H, Jansen AS, Foster GR, Largen P, Cattell V. Expression of the gene for inducible nitric oxide synthase in experimental glomerulonephritis in the rat. Clin Exp Immunol 1994; 97: 315-320
76. Jansen A, Cook T, Taylor GM et al. Induction of nitric oxide synthase in rat immune complex glomerulonephritis. Kidney Int 1994; 45: 1215-1219
77. Noiri E, Peresleni T, Miller F, Goligorsky MS. In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J Clin Invest 1996; 97: 2377-2383
78. Yu L. Nitric oxide in acute renal failure: foe or friend? Kidney Int 1997; 61 [Suppl]: S39-40
79. Mulligan MS, Hevel JM, Marietta MA, Ward PA. Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc Natl Acad Sci USA 1991; 88: 6338-6342
80. Zhang F, Casey RM, Ross ME, Iadecola C. Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion. Stroke 1996; 27: 317-323
81. Nozik ES, Huang YC, Piantadosi CA. L-Arginine enhances injury in the isolated rabbit lung during hyperoxia. Respir Physiol 1995; 100: 63-74
82. Neilly PJ, Kirk SJ, Gardiner KR, Anderson NH, Rowlands BJ. Manipulation of the L-arginine-nitric oxide pathway in experimental colitis. Br J Surg 1995; 82: 1188-1191
83. Cattell V, Cook T, Moncada S. Glomeruli synthesize nitrite in experimental nephrotoxic nephritis. Kidney Int 1990; 38: 1056-1060
84. Cattell V. Macrophages in acute glomerular inflammation. Kidney Int 1994; 45: 945-952
85. Cattell V. Nitric oxide-potential mediator in glomerulonephritis? Nephrol Dial Transplant 1995; 10: 759-774
86. Waddington S, Cook TH, Reaveley D, Jansen A, Cattell V. L-Arginine depletion inhibits glomerular nitric oxide synthesis and exacerbates rat nephrotoxic nephritis. Kidney Int 1996; 49: 1090-1096
87. Cattell V, Cook HT, Ebrahim H et al. Anti-GBM glomerulonephritis in mice lacking nitric oxide synthase type 2. Kidney Int 1998; 53: 932-936
88. Chen PY, Sanders PW. L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest 1991; 88: 1559-1567
89. Vouldoukis I, Riveros Moreno V, Dugas B et al. The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen. Proc Natl Acad Sci USA 1995; 92: 7804-7808
90. Nicholson S, Bonecini Almeida M, Lapa S et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 1996; 183: 2293-2302
91. Sakurai H, Kohsaka H, Liu MF et al. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 1995; 96: 2357-2363
92. Wheeler MA, Smith SD, Garcia Cardena G, Nathan CF, Weiss RM, Sessa WC. Bacterial infection induces nitric oxide synthase in human neutrophils. J Clin Invest 1997; 99: 110-116
93. Bukrinsky MI, Nottet HS, Schmidtmayerova H et al. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med 1995; 181: 735-745
94. Adamson DC, Wildemann B, Sasaki M et al. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 1996; 274: 1917-1921
95. MacMillan Crow LA, Crow JP, Kerby JD, Beckman JS, Thompson JA. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci USA 1996; 93: 11853-11858
96. Heeringa P, de Jager-Krikken A, Tiebosch TA, Fransen C, Kallenberg CGM, van Goor H. Expression of nitric oxide synthases and peroxynitrite modified proteins in Wegener s granulomatosis. J Am Soc Nephrol 1998; 9: 476 [Abstract]
97. Kashem A, Endoh M, Yano N, Yamauchi F, Nomoto Y, Sakai H. Expression of inducible-NOS in human glomerulonephritis: the possible source is infiltrating monocytes/macrophages. Kidney Int 1996; 50: 392-399
98. Furusu A, Miyazaki M, Abe K et al. Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis. Kidney Int 1998; 53: 1760-1768
99. Ikegaya N, Yamamoto T, Peters H, Pollock J, Border WA, Noble NA. Increased expression of endothelial nitric oxide synthase, TGF-beta1 and matrix proteins in human kidney diseases. J Am Soc Nephrol 1996; 7: 1563 [Abstract]